首页 > 最新文献

International Journal for Quality in Health Care最新文献

英文 中文
Barriers and facilitators to health professionals' engagement in quality improvement initiatives: a mixed-methods systematic review. 卫生专业人员参与质量改进计划的障碍和促进因素:混合方法系统综述》。
IF 2.7 4区 医学 Q1 Medicine Pub Date : 2024-05-21 DOI: 10.1093/intqhc/mzae041
Joanna Elizalde, Jommel Lumibao, Lucylynn Lizarondo

Quality improvement (QI) initiatives in healthcare are crucial for enhancing service quality and healthcare outcomes. The success of these initiatives depends on the active engagement of healthcare professionals, which can be influenced by several factors within the healthcare system. This systematic review synthesized the factors influencing healthcare professionals' engagement in QI projects, focusing on identifying both barriers and facilitators. A mixed methods systematic review (MMSR) was conducted using the JBI methodology for MMSR. Databases such as MEDLINE, CINAHL, Scopus, and Embase were searched for studies that explored barriers and facilitators to QI engagement of health professionals in the clinical setting. Methodological quality was assessed using the Mixed-Methods Appraisal Tool (MMAT). The extracted data were synthesized using the JBI convergent integrated approach to MMSR. Eighteen studies (seven qualitative, nine quantitative, and two mixed-methods) published between 2007 and 2023 were included in the review. The analysis revealed barriers and facilitators to engagement in QI initiatives at different levels of the health system. At the QI program level, the engagement of health professionals to QI was influenced by the approach to QI, evidence underpinning the QI initiative, QI knowledge and training, and access to QI specialists. At the health professional level, barriers and facilitators were related to their organizational role, motivation, perceptions about QI, and collaborations with individuals and groups. At the organizational level, factors related to culture and climate, leadership, available resources (including human resource and workload, infrastructure, and incentives), and institutional priorities influenced health professionals' participation in QI. This review highlights the complex interplay of organizational, individual, and QI program level factors that influence the engagement of healthcare professionals in QI. Overcoming these complex barriers and leveraging facilitators is crucial for enhancing participation in QI efforts. The findings underscore the need for a multi-level strategy that focuses on creating a conducive organizational culture, providing robust leadership, and ensuring adequate resources and training for healthcare professionals. Such strategies hold the potential to enhance the effectiveness and sustainability of QI initiatives in healthcare settings.

背景 医疗质量改进(QI)措施对于提高服务质量和医疗效果至关重要。这些措施的成功与否取决于医疗保健专业人员的积极参与,而这可能受到医疗保健系统内多种因素的影响。本系统综述对影响医疗保健专业人员参与质量改进项目的因素进行了综合分析,重点在于找出障碍和促进因素。方法 采用 JBI 的 MMSR 方法进行了混合方法系统性综述(MMSR)。研究人员在 MEDLINE、CINAHL、Scopus 和 Embase 等数据库中搜索了有关医护人员在临床环境中参与 QI 的障碍和促进因素的研究。采用混合方法评估工具 (MMAT) 对方法学质量进行评估。采用 JBI MMSR 聚合集成方法对提取的数据进行综合。结果 2007 年至 2023 年间发表的 18 项研究(7 项定性研究、9 项定量研究和 2 项混合方法研究)被纳入综述。分析揭示了卫生系统不同层面参与质量改进计划的障碍和促进因素。在质量改进计划层面,卫生专业人员参与质量改进的程度受到质量改进方法、支持质量改进计划的证据、质量改进知识和培训以及与质量改进专家接触的机会的影响。在卫生专业人员层面,障碍和促进因素与他们的组织角色、动机、对质量改进的看法以及与个人和团体的合作有关。在组织层面,与文化和氛围、领导力、可用资源(包括人力资源和工作量、基础设施和激励措施)以及机构优先事项有关的因素影响着卫生专业人员对质量创新的参与。结论 本综述强调了影响医疗保健专业人员参与质量改进的组织、个人和质量改进计划层面因素之间复杂的相互作用。克服这些复杂的障碍和利用促进因素对于提高参与质量改进工作至关重要。研究结果强调,有必要采取多层次的策略,重点是创造有利的组织文化、提供强有力的领导、确保为医护专业人员提供充足的资源和培训。这样的策略有可能提高医疗机构中质量改进措施的有效性和可持续性。
{"title":"Barriers and facilitators to health professionals' engagement in quality improvement initiatives: a mixed-methods systematic review.","authors":"Joanna Elizalde, Jommel Lumibao, Lucylynn Lizarondo","doi":"10.1093/intqhc/mzae041","DOIUrl":"10.1093/intqhc/mzae041","url":null,"abstract":"<p><p>Quality improvement (QI) initiatives in healthcare are crucial for enhancing service quality and healthcare outcomes. The success of these initiatives depends on the active engagement of healthcare professionals, which can be influenced by several factors within the healthcare system. This systematic review synthesized the factors influencing healthcare professionals' engagement in QI projects, focusing on identifying both barriers and facilitators. A mixed methods systematic review (MMSR) was conducted using the JBI methodology for MMSR. Databases such as MEDLINE, CINAHL, Scopus, and Embase were searched for studies that explored barriers and facilitators to QI engagement of health professionals in the clinical setting. Methodological quality was assessed using the Mixed-Methods Appraisal Tool (MMAT). The extracted data were synthesized using the JBI convergent integrated approach to MMSR. Eighteen studies (seven qualitative, nine quantitative, and two mixed-methods) published between 2007 and 2023 were included in the review. The analysis revealed barriers and facilitators to engagement in QI initiatives at different levels of the health system. At the QI program level, the engagement of health professionals to QI was influenced by the approach to QI, evidence underpinning the QI initiative, QI knowledge and training, and access to QI specialists. At the health professional level, barriers and facilitators were related to their organizational role, motivation, perceptions about QI, and collaborations with individuals and groups. At the organizational level, factors related to culture and climate, leadership, available resources (including human resource and workload, infrastructure, and incentives), and institutional priorities influenced health professionals' participation in QI. This review highlights the complex interplay of organizational, individual, and QI program level factors that influence the engagement of healthcare professionals in QI. Overcoming these complex barriers and leveraging facilitators is crucial for enhancing participation in QI efforts. The findings underscore the need for a multi-level strategy that focuses on creating a conducive organizational culture, providing robust leadership, and ensuring adequate resources and training for healthcare professionals. Such strategies hold the potential to enhance the effectiveness and sustainability of QI initiatives in healthcare settings.</p>","PeriodicalId":13800,"journal":{"name":"International Journal for Quality in Health Care","volume":null,"pages":null},"PeriodicalIF":2.7,"publicationDate":"2024-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140898244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The silent threat: investigating sleep disturbances in hospitalized patients. 无声的威胁:调查住院病人的睡眠障碍。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2024-05-20 DOI: 10.1093/intqhc/mzae042
Corey Adams, Reema Harrison, Anthony Schembri, Moira Junge, Ramesh Walpola

Sleep disruptions in the hospital setting can have adverse effects on patient safety and well-being, leading to complications like delirium and prolonged recovery. This study aimed to comprehensively assess the factors influencing sleep disturbances in hospital wards, with a comparison of the sleep quality of patients staying in single rooms to those in shared rooms. A mixed-methods approach was used to examine patient-reported sleep quality and sleep disruption factors, in conjunction with objective noise measurements, across seven inpatient wards at an acute tertiary public hospital in Sydney, Australia. The most disruptive factor to sleep in the hospital was noise, ranked as 'very disruptive' by 20% of patients, followed by acute health conditions (11%) and nursing interventions (10%). Patients in shared rooms experienced the most disturbed sleep, with 51% reporting 'poor' or 'very poor' sleep quality. In contrast, only 17% of the patients in single rooms reported the same. Notably, sound levels in shared rooms surpassed 100 dB, highlighting the potential for significant sleep disturbances in shared patient accommodation settings. The results of this study provide a comprehensive overview of the sleep-related challenges faced by patients in hospital, particularly those staying in shared rooms. The insights from this study offer guidance for targeted healthcare improvements to minimize disruptions and enhance the quality of sleep for hospitalized patients.

背景:医院环境中的睡眠障碍会对患者的安全和健康产生不利影响,导致谵妄等并发症和恢复期延长。本研究旨在全面评估影响非急诊住院病房患者睡眠障碍的因素,并对单人病房和合住病房患者的睡眠质量进行比较:在澳大利亚悉尼的一家急诊三级公立医院的七个住院病房中,采用混合方法对患者报告的睡眠质量和睡眠干扰因素进行了研究,同时还进行了客观噪音测量:20%的患者认为噪音是医院中最影响睡眠的因素,认为其 "非常影响睡眠",其次是急性健康状况(11%)和护理干预(10%)。合住病房的病人睡眠最不安稳,51%的病人表示睡眠质量 "很差 "或 "非常差"。相比之下,只有 17% 的单人病房病人报告了同样的情况。值得注意的是,共用房间的声级超过了 100 分贝,这凸显出在病人共用住宿环境中可能会出现严重的睡眠障碍:这项研究的结果全面概述了住院病人,尤其是合住病房的病人所面临的与睡眠有关的挑战。对病人睡眠干扰最大的因素是噪音,其次是急性病和护理干预。这项研究的见解为有针对性地改善医疗保健提供了指导,从而最大限度地减少干扰,提高住院患者的睡眠质量。
{"title":"The silent threat: investigating sleep disturbances in hospitalized patients.","authors":"Corey Adams, Reema Harrison, Anthony Schembri, Moira Junge, Ramesh Walpola","doi":"10.1093/intqhc/mzae042","DOIUrl":"10.1093/intqhc/mzae042","url":null,"abstract":"<p><p>Sleep disruptions in the hospital setting can have adverse effects on patient safety and well-being, leading to complications like delirium and prolonged recovery. This study aimed to comprehensively assess the factors influencing sleep disturbances in hospital wards, with a comparison of the sleep quality of patients staying in single rooms to those in shared rooms. A mixed-methods approach was used to examine patient-reported sleep quality and sleep disruption factors, in conjunction with objective noise measurements, across seven inpatient wards at an acute tertiary public hospital in Sydney, Australia. The most disruptive factor to sleep in the hospital was noise, ranked as 'very disruptive' by 20% of patients, followed by acute health conditions (11%) and nursing interventions (10%). Patients in shared rooms experienced the most disturbed sleep, with 51% reporting 'poor' or 'very poor' sleep quality. In contrast, only 17% of the patients in single rooms reported the same. Notably, sound levels in shared rooms surpassed 100 dB, highlighting the potential for significant sleep disturbances in shared patient accommodation settings. The results of this study provide a comprehensive overview of the sleep-related challenges faced by patients in hospital, particularly those staying in shared rooms. The insights from this study offer guidance for targeted healthcare improvements to minimize disruptions and enhance the quality of sleep for hospitalized patients.</p>","PeriodicalId":13800,"journal":{"name":"International Journal for Quality in Health Care","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11107945/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140898329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practice patterns and survival outcomes for muscle-invasive bladder cancer: real-life experience in a general population setting. 肌肉浸润性膀胱癌的诊疗模式和生存结果:普通人群的实际经验。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2024-05-18 DOI: 10.1093/intqhc/mzae040
Sandrine D Plouvier, Gautier Marcq, Olivier Vankemmel, Pierre Colin, Jean-Louis Bonnal, Xavier Leroy, Fabien Saint, David Pasquier

Bladder cancer (BC) is a common malignancy in Europe and North America. Among BCs, muscle-invasive BCs (MIBCs) are distinguished, as they require aggressive treatment due to their spreading potential and poor prognosis. Despite its clinical relevance, little information on MIBC in a general population setting is available. This study aims to report practice patterns and survival outcomes for MIBC patients in a general population setting. MIBCs among BC incidence in 2011 and 2012 recorded in a French population-based cancer registry (810 000 inhabitants) were included in the study. Data were extracted from the medical files. Individual, tumour-related characteristics and initial management including diagnostic tools, multidisciplinary team meeting (MDT) assessment, and treatment delivered were described. Cystectomy, chemoradiation, radiotherapy, and chemotherapy were considered as specific treatments. Matching between MDT decision and the treatment provided was detailed. Management practices were discussed according to the guideline's recommendations. Overall survival (using the Kaplan-Meier method) and net survival (using the Pohar-Perme estimator) were calculated. Among 538 incident BC cases, 147 (27.3%) were MIBCs. Diagnostic practices displayed a relevant locoregional assessment of BC. Almost all cases (n = 136, 92.5%) were assessed during an uro-oncological MDT with a median time from diagnosis of 18 days (first quartile:12-third quartile:32). Discrepancies appeared between MDT decisions and treatments delivered: 71 out of 86 subjects received the recommended cystectomy or chemoradiation (with or without neoadjuvant chemotherapy); 6 out of 11 had the recommended radio- or chemotherapy; and 9 patients did not undergo any specific treatment despite the MDT decision. Cystectomy was the most common treatment performed; the time to surgery appeared consistent with the guideline's recommendations. Forty people only received supportive care. Still, the 5-year overall and net survival was poor, with 19% (13-26) and 22% (14-31), respectively. The 5-year net survival was 35% (23-48) for people who underwent curative-intent treatments. MIBC management remains challenging even for cases assessed during an MDT. Many people did not undergo any specific treatment. Prognosis was poor even when curative-intent therapies were delivered. Efforts to reduce exposure to risk factors such as tobacco smoking and occupational exposures must be maintained.

背景:膀胱癌(BC)是欧洲和北美常见的恶性肿瘤:膀胱癌(BC)是欧洲和北美常见的恶性肿瘤。在膀胱癌中,肌层浸润性膀胱癌(MIBC)尤为突出,因为它们具有扩散潜力且预后较差,需要积极治疗。尽管肌肉浸润性膀胱癌与临床密切相关,但目前关于普通人群中肌肉浸润性膀胱癌的信息却很少。本研究旨在报告普通人群中 MIBC 患者的诊疗模式和生存结果:研究对象包括法国癌症人口登记处(81万居民)记录的2011年和2012年BC事件中的MIBC患者。数据从医疗档案中提取。研究描述了个人、肿瘤相关特征和初始管理,包括诊断工具、多学科小组会议(MDT)评估和治疗。膀胱切除术、化疗、放疗和化疗被视为特定的治疗方法。详细介绍了多学科小组会议决定与所提供治疗之间的匹配情况。根据指南建议讨论了管理方法。计算了总生存率(采用 Kaplan-Meier 法)和净生存率(采用 Poher-Perme 估计法):结果:在 538 例 BC 病例中,147 例(27.3%)为 MIBC。诊断方法对 BC 进行了相关的区域评估。几乎所有病例(136 例,92.5%)都是在泌尿肿瘤 MDT 期间进行评估的,诊断时间中位数为 18 天[第一四分位数:12-第三四分位数:32]。MDT的决定与实施的治疗之间存在差异:86名受试者中有71名接受了建议的膀胱切除术或化疗(+/-新辅助化疗);11名受试者中有6名接受了建议的放疗或化疗;9名患者尽管接受了MDT的决定,但未接受任何特定治疗。膀胱切除术是最常见的治疗方法;手术时间似乎与指南的建议一致。40人只接受了支持性治疗。不过,五年总生存率和净生存率都很低,分别为 19% [13-26] 和 22% [14-31]。接受根治性治疗的患者的五年净生存率为 35% [23-48]:结论:即使是在MDT中评估的MIBC病例,其治疗仍然具有挑战性。许多人没有接受任何特定治疗。即使接受了治愈性治疗,预后也很差。必须继续努力减少接触吸烟和职业暴露等风险因素。
{"title":"Practice patterns and survival outcomes for muscle-invasive bladder cancer: real-life experience in a general population setting.","authors":"Sandrine D Plouvier, Gautier Marcq, Olivier Vankemmel, Pierre Colin, Jean-Louis Bonnal, Xavier Leroy, Fabien Saint, David Pasquier","doi":"10.1093/intqhc/mzae040","DOIUrl":"10.1093/intqhc/mzae040","url":null,"abstract":"<p><p>Bladder cancer (BC) is a common malignancy in Europe and North America. Among BCs, muscle-invasive BCs (MIBCs) are distinguished, as they require aggressive treatment due to their spreading potential and poor prognosis. Despite its clinical relevance, little information on MIBC in a general population setting is available. This study aims to report practice patterns and survival outcomes for MIBC patients in a general population setting. MIBCs among BC incidence in 2011 and 2012 recorded in a French population-based cancer registry (810 000 inhabitants) were included in the study. Data were extracted from the medical files. Individual, tumour-related characteristics and initial management including diagnostic tools, multidisciplinary team meeting (MDT) assessment, and treatment delivered were described. Cystectomy, chemoradiation, radiotherapy, and chemotherapy were considered as specific treatments. Matching between MDT decision and the treatment provided was detailed. Management practices were discussed according to the guideline's recommendations. Overall survival (using the Kaplan-Meier method) and net survival (using the Pohar-Perme estimator) were calculated. Among 538 incident BC cases, 147 (27.3%) were MIBCs. Diagnostic practices displayed a relevant locoregional assessment of BC. Almost all cases (n = 136, 92.5%) were assessed during an uro-oncological MDT with a median time from diagnosis of 18 days (first quartile:12-third quartile:32). Discrepancies appeared between MDT decisions and treatments delivered: 71 out of 86 subjects received the recommended cystectomy or chemoradiation (with or without neoadjuvant chemotherapy); 6 out of 11 had the recommended radio- or chemotherapy; and 9 patients did not undergo any specific treatment despite the MDT decision. Cystectomy was the most common treatment performed; the time to surgery appeared consistent with the guideline's recommendations. Forty people only received supportive care. Still, the 5-year overall and net survival was poor, with 19% (13-26) and 22% (14-31), respectively. The 5-year net survival was 35% (23-48) for people who underwent curative-intent treatments. MIBC management remains challenging even for cases assessed during an MDT. Many people did not undergo any specific treatment. Prognosis was poor even when curative-intent therapies were delivered. Efforts to reduce exposure to risk factors such as tobacco smoking and occupational exposures must be maintained.</p>","PeriodicalId":13800,"journal":{"name":"International Journal for Quality in Health Care","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140898324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating drivers of telecare acceptance to improve healthcare quality for independently living older adults. 调查接受远程护理的驱动因素,提高独立生活的老年人的医疗质量。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2024-05-16 DOI: 10.1093/intqhc/mzae039
Walfried Lassar, Attila J Hertelendy

Contemporary telecare systems facilitate the ability for older adults to age in place, keeping them out of residential care facilities and providing numerous quality-of-life advantages for both care receivers (CRs) and caregivers (CGs). However, despite the acceptance of digital health interventions among older adults and their CGs, telecare adoption has been slower than expected. This paper aimed to compare attitudes toward adopting telecare systems between CRs (aging adults) and their CGs (family/friends). Data were collected via an online survey. Respondents included aging adults concerned about their care (CRs) and older adults who cared for an aging loved one (CGs). Analysis of covariance and partial-least-squares techniques were used to examine the relationships between healthcare concerns for older adults, functional telecare benefits, and telecare acceptance. Concerns for healthcare status, mainly driven by CRs, positively impacted telecare acceptance. However, concerns for mental and physical stimulation had a negative relationship with telecare acceptance, while CGs showed a neutral relationship. Telecare's ability to improve healthcare quality and cognitive stimulation positively impacted its acceptance. CGs mainly drove the impact of healthcare quality on telecare acceptance, while the relationship was not significant for CRs. CRs' age reduced telecare acceptance, and higher educational levels of CGs increased telecare acceptance. We found significant differences in telecare acceptance and its drivers between CGs and CRs in the USA. In addition, we discerned that not all healthcare concerns or functional telecare characteristics influenced telecare acceptance equally between the two. Consequently, telecare providers must consider the different needs of constituencies interested in telecare to support the life quality of older adults.

背景--当代远程护理系统有助于老年人居家养老,使他们远离养老院,并为接受护理者和护理人员提供众多生活质量方面的优势。然而,尽管老年人及其护理人员对数字健康干预措施的接受程度很高,但远程护理系统的采用却比预期的要慢。本文旨在比较护理对象(老年人)和护理人员(家人/朋友)对采用远程护理系统的态度。方法 -通过在线调查收集数据。受访者包括关心其护理问题的老年人(护理接受者)和照顾年迈亲人的老年人(护理者)。采用协方差分析和偏最小二乘法技术来研究老年人对医疗保健的担忧、远程护理的功能性益处和远程护理接受度之间的关系。结果--对医疗保健状况的关注(主要由护理接受者驱动)对远程护理的接受度产生了积极影响。但是,对精神和身体刺激的关注与远程护理的接受度呈负相关,而护理人员则呈中性关系。远程护理改善医疗质量和认知刺激的能力对其接受度有积极影响。护理人员主要推动了医疗质量对远程护理接受度的影响,而这种关系对护理对象来说并不显著。护理对象的年龄降低了对远程护理的接受度,而护理人员的教育水平越高,对远程护理的接受度越高。结论 - 我们发现美国护理人员和护理对象在远程护理接受度及其驱动因素方面存在显著差异。此外,我们还发现,并非所有的医疗保健问题或远程护理功能特征都会对两者接受远程护理产生同样的影响。因此,远程护理提供商必须考虑对远程护理感兴趣的不同群体的不同需求,以提高老年人的生活质量。
{"title":"Investigating drivers of telecare acceptance to improve healthcare quality for independently living older adults.","authors":"Walfried Lassar, Attila J Hertelendy","doi":"10.1093/intqhc/mzae039","DOIUrl":"10.1093/intqhc/mzae039","url":null,"abstract":"<p><p>Contemporary telecare systems facilitate the ability for older adults to age in place, keeping them out of residential care facilities and providing numerous quality-of-life advantages for both care receivers (CRs) and caregivers (CGs). However, despite the acceptance of digital health interventions among older adults and their CGs, telecare adoption has been slower than expected. This paper aimed to compare attitudes toward adopting telecare systems between CRs (aging adults) and their CGs (family/friends). Data were collected via an online survey. Respondents included aging adults concerned about their care (CRs) and older adults who cared for an aging loved one (CGs). Analysis of covariance and partial-least-squares techniques were used to examine the relationships between healthcare concerns for older adults, functional telecare benefits, and telecare acceptance. Concerns for healthcare status, mainly driven by CRs, positively impacted telecare acceptance. However, concerns for mental and physical stimulation had a negative relationship with telecare acceptance, while CGs showed a neutral relationship. Telecare's ability to improve healthcare quality and cognitive stimulation positively impacted its acceptance. CGs mainly drove the impact of healthcare quality on telecare acceptance, while the relationship was not significant for CRs. CRs' age reduced telecare acceptance, and higher educational levels of CGs increased telecare acceptance. We found significant differences in telecare acceptance and its drivers between CGs and CRs in the USA. In addition, we discerned that not all healthcare concerns or functional telecare characteristics influenced telecare acceptance equally between the two. Consequently, telecare providers must consider the different needs of constituencies interested in telecare to support the life quality of older adults.</p>","PeriodicalId":13800,"journal":{"name":"International Journal for Quality in Health Care","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140898255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient experience and nurse staffing level in South Korea. 韩国的患者体验与护士配置水平。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2024-05-14 DOI: 10.1093/intqhc/mzae038
Yeongchae Song, Young Kyung Do

Patient experience has recently become a key driver for hospital quality improvement in South Korea, marked by the introduction of the Patient Experience Assessment (PXA) within its National Health Insurance in 2017. While the PXA has garnered special attention from the media and hospitals, there has been a lack of focus on its structural determinants, hindering continuous and sustained improvement in patient experience. Given the relatively low number of practicing nurses per 1000 population in South Korea and the significant variation in nurse staffing levels across hospitals, the staffing level of nurses in hospitals could be a crucial structural determinant of patient experience. This study examines the association between patient experience and hospital nurse staffing levels in South Korea. We used individual- and hospital-level data from the 2019 PXA, encompassing 7250 patients from 42 tertiary hospitals and 16 235 patients from 109 non-tertiary general hospitals with 300 or more beds. The dependent variables were derived from the complete set of 21 proper questions on patient experience in the Nurse and other domains. The main explanatory variable was the hospital-level Nurse Staffing Grade (NSG), employed by the National Health Insurance to adjust reimbursement to hospitals. Multilevel ordered/binomial logistic or linear regression was conducted accounting for other hospital- and patient-level characteristics as well as acknowledging the nested nature of the data. A clear, positive association was observed between patient experience in the Nurse domain and NSG, even after accounting for other characteristics. For example, the predicted probability of reporting the top-box category of "Always" to the question "How often did nurses treat you with courtesy and respect?" was 70.3% among patients from non-tertiary general hospitals with the highest NSG, compared to 63.1% among patients from their peer hospitals with the lowest NSG. Patient experience measured in other domains that were likely to be affected by nurse staffing levels also showed similar associations, although generally weaker and less consistent than in the Nurse domain. Better patient experience was associated with higher hospital nurse staffing levels in South Korea. Alongside current initiatives focused on measuring and publicly reporting patient experience, strengthening nursing and other hospital workforce should also be included in policy efforts to improve patient experience.

背景:2017 年,韩国在国民健康保险(NHI)中引入了 "患者体验评估"(PXA),这标志着患者体验最近已成为韩国医院质量改进的关键驱动力。虽然 PXA 得到了媒体和医院的特别关注,但对其结构性决定因素却缺乏重视,从而阻碍了患者体验的持续改善。鉴于韩国每千人中执业护士的数量相对较低,且各医院的护士人员配备水平差异显著,医院的护士人员配备水平可能是患者体验的一个关键结构性决定因素。本研究探讨了韩国患者就医体验与医院护士配置水平之间的关系:我们使用了来自 2019 年 PXA 的个人和医院层面的数据,其中包括来自 42 家三级医院的 7250 名患者和来自 109 家拥有 300 张或以上床位的非三级综合医院的 16235 名患者。因变量来自全套 21 个有关护士和其他领域患者体验的适当问题。主要解释变量是医院层面的护士配置等级(NSG),国家医疗保险采用该等级来调整医院的报销额度。考虑到其他医院和患者层面的特征以及数据的嵌套性质,进行了多层次有序/二项式逻辑或线性回归:结果:即使考虑了其他特征,护士领域的患者体验与 NSG 之间仍存在明显的正相关。例如,在 NSG 最高的非三级综合医院的患者中,对 "护士多长时间以礼貌和尊重的态度对待您一次?"这一问题回答顶部方框类别 "总是 "的预测概率为 70.3%,而在 NSG 最低的同级医院的患者中,这一概率为 63.1%。在其他可能受护士人员配备水平影响的领域测量的患者体验也显示出类似的关联性,但一般比护士领域的关联性要弱,也不那么一致:在韩国,较好的患者体验与较高的医院护士配置水平有关。除了目前以衡量和公开报告患者体验为重点的举措外,加强护理和其他医院劳动力也应纳入改善患者体验的政策努力中。
{"title":"Patient experience and nurse staffing level in South Korea.","authors":"Yeongchae Song, Young Kyung Do","doi":"10.1093/intqhc/mzae038","DOIUrl":"10.1093/intqhc/mzae038","url":null,"abstract":"<p><p>Patient experience has recently become a key driver for hospital quality improvement in South Korea, marked by the introduction of the Patient Experience Assessment (PXA) within its National Health Insurance in 2017. While the PXA has garnered special attention from the media and hospitals, there has been a lack of focus on its structural determinants, hindering continuous and sustained improvement in patient experience. Given the relatively low number of practicing nurses per 1000 population in South Korea and the significant variation in nurse staffing levels across hospitals, the staffing level of nurses in hospitals could be a crucial structural determinant of patient experience. This study examines the association between patient experience and hospital nurse staffing levels in South Korea. We used individual- and hospital-level data from the 2019 PXA, encompassing 7250 patients from 42 tertiary hospitals and 16 235 patients from 109 non-tertiary general hospitals with 300 or more beds. The dependent variables were derived from the complete set of 21 proper questions on patient experience in the Nurse and other domains. The main explanatory variable was the hospital-level Nurse Staffing Grade (NSG), employed by the National Health Insurance to adjust reimbursement to hospitals. Multilevel ordered/binomial logistic or linear regression was conducted accounting for other hospital- and patient-level characteristics as well as acknowledging the nested nature of the data. A clear, positive association was observed between patient experience in the Nurse domain and NSG, even after accounting for other characteristics. For example, the predicted probability of reporting the top-box category of \"Always\" to the question \"How often did nurses treat you with courtesy and respect?\" was 70.3% among patients from non-tertiary general hospitals with the highest NSG, compared to 63.1% among patients from their peer hospitals with the lowest NSG. Patient experience measured in other domains that were likely to be affected by nurse staffing levels also showed similar associations, although generally weaker and less consistent than in the Nurse domain. Better patient experience was associated with higher hospital nurse staffing levels in South Korea. Alongside current initiatives focused on measuring and publicly reporting patient experience, strengthening nursing and other hospital workforce should also be included in policy efforts to improve patient experience.</p>","PeriodicalId":13800,"journal":{"name":"International Journal for Quality in Health Care","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140863073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medication reuse programs: a narrative review of the literature 药物再利用计划:文献综述
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2024-04-30 DOI: 10.1093/intqhc/mzae036
Samuel Watts, John Coutsouvelis, Joanne Wickens, Susan Poole, Mia Percival, John R Zalcberg
A proportion of returned medications may potentially meet quality standards to be reused safely. In Australia, there is no regulatory guidance available to facilitate such medication reuse. This narrative review aimed to identify and review international literature describing medication reuse programs to provide insight into their implementation and potential barriers. Using the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) -based guidelines, a literature search was conducted in Medline, Scopus, and Embase using key words such as ‘medication’ and ‘reuse’ to identify relevant articles. Two reviewers ascertained eligibility for inclusion. Inclusion criteria included English language and publication after 2010. From the articles selected, identified international medication reuse programs and relevant regulatory aspects were summarized. Details, both regulatory and operational, for the specific medication reuse programs, described in the selected articles was further explored via a grey literature search. Of the 1973 identified articles, 84 were assessed for eligibility and 17 were included in this review. Of these, 14 described scenarios where medication reuse is prohibited, 2 studies described programs allowing the reuse of medication and 1 study did not discuss whether reuse was prohibited or not. From these primary articles, secondary citations were identified, with eight from gray literature. Barriers to medication reuse included exposure to environmental extremes during storage, physical appearance, evidence of tampering, safety, and efficacy concerns for the returned medication. Programs that exist globally have overcome these barriers. Several programs that provide safe and effective reuse of medications were i© The Author(s) 2024. Published by Oxford University Press on behalf of International Society for Quality in Health Care. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site–for further information please contact journals.permissions@oup.com.dentified and described. The findings described in this review should be used to inform frameworks for legislative, regulatory, and professional practice change for medication reuse. Measures implemented in the UK’s pandemic response to safely reuse medications in the nursing home and hospice settings and European medication donation programs should be further investigated. The concept of medication reuse is not novel and should be considered for the Australian setting.
一部分退回的药品可能符合安全再利用的质量标准。在澳大利亚,目前尚无促进此类药物再利用的监管指南。本叙述性综述旨在识别和回顾描述药物再利用计划的国际文献,以深入了解其实施情况和潜在障碍。采用基于系统性综述和元分析的首选报告项目(PRISMA)指南,在 Medline、Scopus 和 Embase 中使用 "药物 "和 "再利用 "等关键词进行文献检索,以确定相关文章。两名审稿人确定了纳入资格。纳入标准包括英语和 2010 年之后发表的文章。从所选文章中,对已确定的国际药物再利用计划和相关监管方面进行了总结。通过灰色文献检索进一步探究了所选文章中描述的具体药物再利用计划的监管和操作细节。在 1973 篇已确定的文章中,84 篇经过资格评估,17 篇被纳入本综述。在这些文章中,14 篇描述了禁止重复使用药物的情况,2 篇研究描述了允许重复使用药物的计划,1 篇研究没有讨论是否禁止重复使用药物。从这些主要文章中确定了二次引用,其中 8 篇来自灰色文献。药物重复使用的障碍包括药物在储存过程中暴露于极端环境、外观、篡改证据、安全性以及退回药物的疗效问题。全球已有的计划克服了这些障碍。有几项计划提供了安全有效的药物再利用服务。由牛津大学出版社代表国际医疗质量学会出版。保留所有权利。如需商业性再利用,请联系 reprints@oup.com 以获取重印和转载的翻译权。所有其他许可均可通过我们网站文章页面上的 "许可 "链接,通过我们的 "权利链接 "服务获得,如需了解更多信息,请联系 journals.permissions@oup.com.dentified。本综述中描述的研究结果应用于药物再利用的立法、监管和专业实践变革框架。应进一步研究英国为应对大流行而实施的在养老院和临终关怀机构安全重复使用药物的措施以及欧洲的药物捐赠计划。药物再利用的概念并不新颖,澳大利亚也应加以考虑。
{"title":"Medication reuse programs: a narrative review of the literature","authors":"Samuel Watts, John Coutsouvelis, Joanne Wickens, Susan Poole, Mia Percival, John R Zalcberg","doi":"10.1093/intqhc/mzae036","DOIUrl":"https://doi.org/10.1093/intqhc/mzae036","url":null,"abstract":"A proportion of returned medications may potentially meet quality standards to be reused safely. In Australia, there is no regulatory guidance available to facilitate such medication reuse. This narrative review aimed to identify and review international literature describing medication reuse programs to provide insight into their implementation and potential barriers. Using the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) -based guidelines, a literature search was conducted in Medline, Scopus, and Embase using key words such as ‘medication’ and ‘reuse’ to identify relevant articles. Two reviewers ascertained eligibility for inclusion. Inclusion criteria included English language and publication after 2010. From the articles selected, identified international medication reuse programs and relevant regulatory aspects were summarized. Details, both regulatory and operational, for the specific medication reuse programs, described in the selected articles was further explored via a grey literature search. Of the 1973 identified articles, 84 were assessed for eligibility and 17 were included in this review. Of these, 14 described scenarios where medication reuse is prohibited, 2 studies described programs allowing the reuse of medication and 1 study did not discuss whether reuse was prohibited or not. From these primary articles, secondary citations were identified, with eight from gray literature. Barriers to medication reuse included exposure to environmental extremes during storage, physical appearance, evidence of tampering, safety, and efficacy concerns for the returned medication. Programs that exist globally have overcome these barriers. Several programs that provide safe and effective reuse of medications were i© The Author(s) 2024. Published by Oxford University Press on behalf of International Society for Quality in Health Care. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site–for further information please contact journals.permissions@oup.com.dentified and described. The findings described in this review should be used to inform frameworks for legislative, regulatory, and professional practice change for medication reuse. Measures implemented in the UK’s pandemic response to safely reuse medications in the nursing home and hospice settings and European medication donation programs should be further investigated. The concept of medication reuse is not novel and should be considered for the Australian setting.","PeriodicalId":13800,"journal":{"name":"International Journal for Quality in Health Care","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140835673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Key lessons to improve care-factors contributing to delayed discharges and cost implications: medical conditions and rehabilitation delays at a tertiary rehabilitation center in Saudi Arabia. 改善护理的关键经验--导致延迟出院的因素及成本影响:沙特阿拉伯一家三级康复中心的医疗条件和康复延迟。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2024-04-26 DOI: 10.1093/intqhc/mzae027
Poonam Gupta, David Greenfield
{"title":"Key lessons to improve care-factors contributing to delayed discharges and cost implications: medical conditions and rehabilitation delays at a tertiary rehabilitation center in Saudi Arabia.","authors":"Poonam Gupta, David Greenfield","doi":"10.1093/intqhc/mzae027","DOIUrl":"https://doi.org/10.1093/intqhc/mzae027","url":null,"abstract":"","PeriodicalId":13800,"journal":{"name":"International Journal for Quality in Health Care","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140851280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A scoping review of the methodological approaches used in retrospective chart reviews to validate adverse event rates in administrative data 对用于验证行政数据中不良事件发生率的回顾性病历审查方法进行范围界定审查
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2024-04-25 DOI: 10.1093/intqhc/mzae037
Anna Connolly, Marcia Kirwan, Anne Matthews
Background Patient safety is a key quality issue for health systems. Healthcare acquired adverse events (AEs) compromise safety and quality; therefore, their reporting and monitoring is a patient safety priority. Although administrative datasets are potentially efficient tools for monitoring rates of adverse events, concerns remain over the accuracy of their data. Chart review validation studies are required to explore the potential of administrative data to inform research and health policy. This review aims to present an overview of the methodological approaches and strategies used to validate rates of adverse events in administrative data through chart review. Methodology This review was conducted in line with the Joanna Briggs Institute methodological framework for scoping reviews. Through database searches, 1054 sources were identified, imported into Covidence, and screened against the inclusion criteria. Articles that validated rates of AEs in administrative data through chart review were included. Data were extracted, exported to Microsoft Excel, arranged into a charting table, and presented in a tabular and descriptive format. Results Fifty-six studies were included. Most sources reported on surgical adverse events however, other medical specialties were also explored. Chart reviews were used in all studies, however few agreed on terminology for the study design. Various methodological approaches and sampling strategies were used. Some studies used the Global Trigger Tool, a two-stage chart review method, whilst others used alternative single-, two-stage or unclear approaches. The sources used samples of flagged charts (n=24), flagged and random charts (n=11) and random charts (n=21). Most studies reported poor or moderate accuracy of adverse event rates. Some studies reported good accuracy of adverse event recording which highlights the potential of using administrative data for research purposes. Conclusions This review highlights the potential for administrative data to provide information on adverse event rates and improve patient safety and healthcare quality. Nonetheless, further work is warranted to ensure that administrative data are accurate. The variation of methodological approaches taken, and sampling techniques used demonstrate a lack of consensus on best practice, therefore, further clarity and consensus are necessary to develop a more systematic approach to chart reviewing.
背景 患者安全是医疗系统的关键质量问题。医疗不良事件(AEs)会影响医疗安全和质量;因此,报告和监测不良事件是患者安全的当务之急。尽管行政数据集是监测不良事件发生率的潜在有效工具,但其数据的准确性仍令人担忧。需要进行病历回顾验证研究,以探索行政数据为研究和卫生政策提供信息的潜力。本综述旨在概述通过病历审查验证行政数据中不良事件发生率的方法和策略。方法 本综述按照乔安娜-布里格斯研究所(Joanna Briggs Institute)的范围界定综述方法框架进行。通过数据库搜索,确定了 1054 个资料来源,将其导入 Covidence,并根据纳入标准进行筛选。通过病历审查验证行政数据中AEs发生率的文章被纳入其中。提取数据并导出至 Microsoft Excel,将其排列成图表,并以表格和描述性格式呈现。结果 共纳入 56 项研究。大多数资料来源报告的是外科不良事件,但也探讨了其他医学专科的不良事件。所有研究都使用了病历回顾,但很少有研究就研究设计的术语达成一致。研究采用了多种方法和抽样策略。一些研究使用了全球触发工具(一种两阶段病历审查方法),而其他研究则使用了其他单阶段、两阶段或不明确的方法。资料来源使用的样本包括标记图表(n=24)、标记和随机图表(n=11)以及随机图表(n=21)。大多数研究报告不良事件发生率的准确性较差或中等。一些研究报告不良事件记录的准确性较好,这凸显了将管理数据用于研究目的的潜力。结论 本综述强调了管理数据在提供不良事件发生率信息、改善患者安全和医疗质量方面的潜力。然而,要确保行政数据的准确性,还需要进一步的努力。所采用的方法和抽样技术各不相同,这表明在最佳实践方面缺乏共识,因此有必要进一步明确和达成共识,以制定更系统的图表审查方法。
{"title":"A scoping review of the methodological approaches used in retrospective chart reviews to validate adverse event rates in administrative data","authors":"Anna Connolly, Marcia Kirwan, Anne Matthews","doi":"10.1093/intqhc/mzae037","DOIUrl":"https://doi.org/10.1093/intqhc/mzae037","url":null,"abstract":"Background Patient safety is a key quality issue for health systems. Healthcare acquired adverse events (AEs) compromise safety and quality; therefore, their reporting and monitoring is a patient safety priority. Although administrative datasets are potentially efficient tools for monitoring rates of adverse events, concerns remain over the accuracy of their data. Chart review validation studies are required to explore the potential of administrative data to inform research and health policy. This review aims to present an overview of the methodological approaches and strategies used to validate rates of adverse events in administrative data through chart review. Methodology This review was conducted in line with the Joanna Briggs Institute methodological framework for scoping reviews. Through database searches, 1054 sources were identified, imported into Covidence, and screened against the inclusion criteria. Articles that validated rates of AEs in administrative data through chart review were included. Data were extracted, exported to Microsoft Excel, arranged into a charting table, and presented in a tabular and descriptive format. Results Fifty-six studies were included. Most sources reported on surgical adverse events however, other medical specialties were also explored. Chart reviews were used in all studies, however few agreed on terminology for the study design. Various methodological approaches and sampling strategies were used. Some studies used the Global Trigger Tool, a two-stage chart review method, whilst others used alternative single-, two-stage or unclear approaches. The sources used samples of flagged charts (n=24), flagged and random charts (n=11) and random charts (n=21). Most studies reported poor or moderate accuracy of adverse event rates. Some studies reported good accuracy of adverse event recording which highlights the potential of using administrative data for research purposes. Conclusions This review highlights the potential for administrative data to provide information on adverse event rates and improve patient safety and healthcare quality. Nonetheless, further work is warranted to ensure that administrative data are accurate. The variation of methodological approaches taken, and sampling techniques used demonstrate a lack of consensus on best practice, therefore, further clarity and consensus are necessary to develop a more systematic approach to chart reviewing.","PeriodicalId":13800,"journal":{"name":"International Journal for Quality in Health Care","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140803355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primum non nocere: first, do no harm-determining the current, ongoing, and future contribution of smart healthcare. Primum non noocere(不伤害原则):首先,不伤害--确定智能医疗在当前、当前和未来的贡献。
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2024-04-22 DOI: 10.1093/intqhc/mzae025
Daniel Wu, David Greenfield, Pa-Chun Wang
{"title":"Primum non nocere: first, do no harm-determining the current, ongoing, and future contribution of smart healthcare.","authors":"Daniel Wu, David Greenfield, Pa-Chun Wang","doi":"10.1093/intqhc/mzae025","DOIUrl":"10.1093/intqhc/mzae025","url":null,"abstract":"","PeriodicalId":13800,"journal":{"name":"International Journal for Quality in Health Care","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140852554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation remains the biggest challenge to the effective use of PROMs and PREMs, so what can we do about it? 实施仍然是有效使用 PROM 和 PREM 的最大挑战,那么我们能做些什么呢?
IF 2.6 4区 医学 Q1 Medicine Pub Date : 2024-04-22 DOI: 10.1093/intqhc/mzae029
Claudia Bull, Jason D Pole
{"title":"Implementation remains the biggest challenge to the effective use of PROMs and PREMs, so what can we do about it?","authors":"Claudia Bull, Jason D Pole","doi":"10.1093/intqhc/mzae029","DOIUrl":"10.1093/intqhc/mzae029","url":null,"abstract":"","PeriodicalId":13800,"journal":{"name":"International Journal for Quality in Health Care","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140849487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal for Quality in Health Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1